# Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential

> **NCT02183285** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 203 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Pharmaton PHL 00747 soft gelatine capsules
- **DIETARY_SUPPLEMENT:** Pharmaton PHL 00747 film-coated tablets
- **DIETARY_SUPPLEMENT:** Placebo film-coated tablets (fct)
- **DIETARY_SUPPLEMENT:** Placebo soft gelatine capsules

## Key facts

- **NCT ID:** NCT02183285
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2004-03
- **Final completion:** —
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183285, "Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02183285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*